Emvision sets sight on us with us$10m keysight investment

Sydney--(business wire)--emvision, an australian medical device company focused on developing innovative portable brain imaging technology, has announced a us$10 million (~a$15.28m) strategic investment from keysight technologies, a global leader in test and measurement technology. the investment provides emvision with a fully funded commercial runway for its emu™ device. it accelerates clinical trials, generating essential data supporting the upcoming regulatory approval pathway and adoption i.
KEYS Ratings Summary
KEYS Quant Ranking